Proxy Votes Now

Home › Funds › Lazard › Lazard US Systematic Small Cap Equity Portfolio

Lazard US Systematic Small Cap Equity Portfolio (LUSIX) proxy voting record 2025-2026

Fund family: Lazard · Filed by LAZARD FUNDS INC (CIK 874964) · SEC series S000074073

Share classes and tickers: LUSIX (C000231513), LUSOX (C000231514), RUSRX (C000231515)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 424 with, 0 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Lazard as a whole

The same two figures as Lazard’s manager page (35,531 ballot items across 33 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsLazardItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)81.2%39889.1%28,705
Backed environmental and social shareholder proposals at US companiesn/a018.4%272

Where this fund voted differently from most Lazard funds

Each ballot item this fund voted is set against the votes of the other Lazard funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most Lazard funds on all 8 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 72.9% of this fund’s 424 such votes could be given a sector; the other 115 (27.1%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary8900.0%
Technology8800.0%
Industrials3700.0%
Health Care2800.0%
Finance2100.0%
Energy1000.0%
Utilities900.0%
Miscellaneous800.0%
Telecommunications800.0%
Consumer Staples700.0%
Real Estate400.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2700
Audit-related500
Say-on-Pay410
Corporate Governance250
Compensation200
Extraordinary Transactions120
Capital Structure80
Shareholder Rights and Defenses10

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
NetScout Systems, Inc.September 10, 2025$347,59070
Nutex Health Inc.July 14, 2025$292,054100
Korn FerrySeptember 18, 2025$229,878110
Commvault Systems, Inc.August 7, 2025$226,677120
Phibro Animal Health CorporationNovember 4, 2025$215,37360
EnerSysJuly 31, 2025$207,04550
Agilysys, Inc.September 4, 2025$201,851100
Cirrus Logic, Inc.July 29, 2025$200,09290

Search this fund’s votes by company

427 ballot items at 59 meetings in 2025-2026. Download all votes (CSV)

About this fund’s record

In the 2025-2026 proxy season, Lazard US Systematic Small Cap Equity Portfolio (LUSIX) voted at 59 shareholder meetings of 59 companies, on 427 ballot items in all. Where management made a recommendation, the fund followed it on 100.0% of the items and voted against it 0 times. It voted FOR the board's own proposals less often than Lazard's funds as a whole (81.2% against 89.1%). It voted the same way as most Lazard funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Lazard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.